Armstrong Advisory Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.2K Hold
127
﹤0.01% 521
2026
Q1
$26.8K Hold
127
﹤0.01% 509
2025
Q4
$26.1K Hold
127
﹤0.01% 513
2025
Q3
$19.9K Sell
127
-87
-41% -$13.4K ﹤0.01% 565
2025
Q2
$36K Hold
214
﹤0.01% 439
2025
Q1
$25.3K Hold
214
﹤0.01% 471
2024
Q4
$25.3K Hold
214
﹤0.01% 471
2024
Q3
$23.7K Hold
214
﹤0.01% 481
2024
Q2
$21K Buy
214
+87
+69% +$8.87K ﹤0.01% 490
2024
Q1
$12.8K Hold
127
﹤0.01% 540
2023
Q4
$12.8K Hold
127
﹤0.01% 540
2023
Q3
$11K Hold
127
﹤0.01% 583
2023
Q2
$12K Hold
127
﹤0.01% 553
2023
Q1
$9.59K Hold
127
﹤0.01% 578
2022
Q4
$9.76K Buy
+127
New +$9.65K ﹤0.01% 588

Other funds holding CAH

Armstrong Advisory Group's CAH Position: Q2 2026 in Review

Armstrong Advisory Group held its Cardinal Health (CAH) position steady in Q2 2026 at 127 shares worth $30.2K. The position accounts for ﹤0.01% of the portfolio, ranked #521.

Armstrong Advisory Group first reported a position in CAH in Q4 2022 and has held it in 15 quarters since. The position peaked at $36K in Q2 2025. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Armstrong Advisory Group held 127 shares of Cardinal Health worth $30.2K as of Q2 2026.
  • Armstrong Advisory Group left its Cardinal Health share count unchanged in Q2 2026.
  • Cardinal Health made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q2 2026, its #521 holding.
  • Armstrong Advisory Group first reported a position in Cardinal Health in Q4 2022 and has held it in 15 quarters since.
  • Armstrong Advisory Group's Cardinal Health position peaked at $36K in Q2 2025.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Armstrong Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.